EODData

FRA, R5XA: ACELRX PHARMACEUT. DL-01

05 Nov 2025
LAST:

1.090

CHANGE:
 0.10
OPEN:
1.090
HIGH:
1.090
ASK:
0.000
VOLUME:
384
CHG(%):
8.25
PREV:
1.188
LOW:
1.090
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 251.0901.0901.0901.090384
04 Nov 251.1881.1881.1881.188384
03 Nov 251.1381.1381.1381.138384
31 Oct 251.0561.0561.0561.056384
30 Oct 251.0361.0361.0361.036384
29 Oct 251.0581.0581.0581.058384
28 Oct 251.0581.0581.0581.058384
27 Oct 250.9780.9780.9780.978384
24 Oct 250.9650.9650.9650.965384
23 Oct 250.9980.9980.9980.998384

COMPANY PROFILE

Name:ACELRX PHARMACEUT. DL-01
About:Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Sector:Healthcare
Address:1850 Gateway Drive, San Mateo, CA, United States, 94404
Website:https://talphera.com
ISIN:US00444T2096

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:0.17 
PEG Ratio:-0.01 
Price to Sales:2,163.32 
Price to Book:3.68 
Operating Margin:-494.59 
Return on Assets:-0.40 
Return on Equity:-1.18 
Revenue:23.4K 
Shares:20.5M 
Market Cap:22.35M 

TECHNICAL INDICATORS

MA5:1.101.1%
MA10:1.063.2%
MA20:1.026.5%
MA50:0.8035.6%
MA100:0.5790.1%
MA200:0.54103.1%
STO9:56.05
STO14:65.85
RSI14:62.72 
WPR14:-34.15
MTM14:0.13
ROC14:0.13 
ATR:0.04 
Week High:1.199.0%
Week Low:1.045.2%
Month High:1.199.0%
Month Low:0.80103.1%
Year High:1.199.0%
Year Low:0.30268.2%
Volatility:116.79 

RECENT SPLITS

Date Ratio
26 Oct 20221-20